Overview

Price chart · mood · technical indicators

SENS

Senseonics Holdings Incstock Healthcare

Medical Devices

$5.0162.05%Current Market Mood:Strong Bearish

Market Mood

Price Range (1Y)

$4.96$14.96

Current: $5.01

Market Comparison

vs Healthcare Sector & Medical Devices Industry

SENS

-62.05%

1Y Performance

Fundamentals

Updated daily after market close

P/E ratio—Forward 21.01

EPS (TTM)$-1.660.0% YoY

Profit margin-196.0%HEALTHCARE

Market cap$213.2MMicro cap

Wall Street coverage

$18.92median target· current $10.09 (+87.5%)8 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 21.01
PEG ratio: 0.00
P/B: 3.50
P/S (TTM): 6.05
EV/EBITDA: 1.76

Profitability & growth

ROE (TTM): -168.3%
Operating margin: -146.8%
Revenue growth YoY: 71.8%
Dividend yield: —
Beta: 1.06

Last earnings

Feb 26, 2026 · Estimate $-0.02 · Reported $-0.46

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Senseonics Holdings, Inc. Common Stock

Company profile

Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.

Classification

Sector: Healthcare
Industry: Medical Devices
Exchange: NYSE MKT
Country: USA
Currency: USD

Company profile

HQ: 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$213.2M

Shares outstanding$41.8M

52W high$14.96

52W low$4.96

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

SENS

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Press Release: Senseonics Enters Into Amended Loan Agreement With Hercules to Increase Borrowing Capacity to $140 Million

Senseonics Holdings Inc (abbreviated as Senseonics) announced that it has significantly increased the maximum borrowing limit under its existing credit arrangement from 100 million dollars to 140 million dollars through a second amendment to the agreement

SENS Stock Sinks As Senseonics’ $80M Offering Triggers Heavy Selling

Senseonics (SENS) files prospectus to sell 8M shares and 8M pre-funded warrants

Senseonics Holdings Boosts Capital via Equity and Loan Expansion

Senseonics will post Q1 results May 7, then hold a 4:30 p.m. webcast

Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time

Senseonics (NASDAQ: SENS) raises $80M, targets larger $140M credit line

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

[424B5] Senseonics Holdings, Inc. Prospectus Supplement (Debt Securities)

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Senseonics prices $80 million public offering at $5 per share By Investing.com

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Diabetes device maker Senseonics seeks $80M for Eversense 365

Senseonics Launches Eversense 365 Continuous Glucose Monitoring System in Sweden, Expanding to Europe

A diabetes monitor that lasts a year reaches first patients in Sweden

Senseonics announces transfer to Nasdaq

Senseonics Holdings announces underwritten public offering

Senseonics Holdings announces underwritten public offering

About Senseonics Holdings, Inc. Common Stock

Classification

Company profile

SENS

Market Comparison

SENS Market Analysis

Overview

SENS

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Press Release: Senseonics Enters Into Amended Loan Agreement With Hercules to Increase Borrowing Capacity to $140 Million

Senseonics Holdings Inc (abbreviated as Senseonics) announced that it has significantly increased the maximum borrowing limit under its existing credit arrangement from 100 million dollars to 140 million dollars through a second amendment to the agreement

SENS Stock Sinks As Senseonics’ $80M Offering Triggers Heavy Selling

Senseonics (SENS) files prospectus to sell 8M shares and 8M pre-funded warrants

Senseonics Holdings Boosts Capital via Equity and Loan Expansion

Senseonics will post Q1 results May 7, then hold a 4:30 p.m. webcast

Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time

Senseonics (NASDAQ: SENS) raises $80M, targets larger $140M credit line

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

[424B5] Senseonics Holdings, Inc. Prospectus Supplement (Debt Securities)

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Senseonics prices $80 million public offering at $5 per share By Investing.com

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Diabetes device maker Senseonics seeks $80M for Eversense 365

Senseonics Launches Eversense 365 Continuous Glucose Monitoring System in Sweden, Expanding to Europe

A diabetes monitor that lasts a year reaches first patients in Sweden

Senseonics announces transfer to Nasdaq

Senseonics Holdings announces underwritten public offering

Senseonics Holdings announces underwritten public offering

About Senseonics Holdings, Inc. Common Stock

Classification

Company profile

SENS

Market Comparison